Modèles transgéniques pour l'étude de la fonction ... - Epublications

Hwang, H. Y., Olson, S. K., Esko, J. D. and Horvitz, H. R. (2003). Caenorhabditis
elegans early embryogenesis and vulval morphogenesis require chondroitin biosynthesis. Nature
423, 439-43.
Ingold, K., Zumsteg, A., Tardivel, A., Huard, B., Steiner, Q. G., Cachero, T. G.,
Qiang, F., Gorelik, L., Kalled, S. L., Acha-Orbea, H. et al. (2005). Identification of
proteoglycans as the APRIL-specific binding partners. J Exp Med 201, 1375-83.
Inlay, M., Alt, F. W., Baltimore, D. and Xu, Y. (2002). Essential roles of the kappa light
chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation. Nat Immunol
3, 463-8.
Iozzo, R. V. (1998). Matrix proteoglycans: from molecular design to cellular function.
Annu Rev Biochem 67, 609-52.
Iritani, B. M., Forbush, K. A., Farrar, M. A. and Perlmutter, R. M. (1997). Control of
B cell development by Ras-mediated activation of Raf. Embo J 16, 7019-31.
Ito, S., Nagaoka, H., Shinkura, R., Begum, N., Muramatsu, M., Nakata, M. and
Honjo, T. (2004). Activation-induced cytidine deaminase shuttles between nucleus and
cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc Natl Acad Sci U S A
101, 1975-80.
Jack, H. M. and Wabl, M. (1988). Immunoglobulin mRNA stability varies during B
lymphocyte differentiation. Embo J 7, 1041-6.
Jacob, J., Kassir, R. and Kelsoe, G. (1991). In situ studies of the primary immune
response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell
populations. J Exp Med 173, 1165-75.
Jefferis, R. (2005). Glycosylation of recombinant antibody therapeutics. Biotechnol Prog
21, 11-6.
Jego, P., Joly, J. and Boisseau, C. (1980). [Amphibian jelly envelopes (proteins secreted
by the oviduct) and their role in fertilization]. Reprod Nutr Dev 20, 557-67.
Johnson, G. L. and Lapadat, R. (2002). Mitogen-activated protein kinase pathways
mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-2.
Jung, D., Giallourakis, C., Mostoslavsky, R. and Alt, F. W. (2006). Mechanism and
control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 24,
541-70.
Kabak, S., Skaggs, B. J., Gold, M. R., Affolter, M., West, K. L., Foster, M. S.,
Siemasko, K., Chan, A. C., Aebersold, R. and Clark, M. R. (2002). The direct recruitment of
BLNK to immunoglobulin alpha couples the B-cell antigen receptor to distal signaling pathways.
Mol Cell Biol 22, 2524-35.
Kabat, E. A. (1956). Heterogeneity in extent of the combining regions of human
antidextran. J Immunol 77, 377-85.
Kadesch, T., Zervos, P. and Ruezinsky, D. (1986). Functional analysis of the murine
IgH enhancer: evidence for negative control of cell-type specificity. Nucleic Acids Res 14, 8209-
21.
Kadonaga, J. T. (1998). Eukaryotic transcription: an interlaced network of transcription
factors and chromatin-modifying machines. Cell 92, 307-13.
Kaisho, T., Schwenk, F. and Rajewsky, K. (1997). The roles of gamma 1 heavy chain
membrane expression and cytoplasmic tail in IgG1 responses. Science 276, 412-5.
Kallies, A. and Nutt, S. L. (2007). Terminal differentiation of lymphocytes depends on
Blimp-1. Curr Opin Immunol 19, 156-62.
Kaneko, Y., Nimmerjahn, F. and Ravetch, J. V. (2006). Anti-inflammatory activity of
immunoglobulin G resulting from Fc sialylation. Science 313, 670-3.
162